共 50 条
- [21] Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase 3 TrialARTHRITIS & RHEUMATOLOGY, 2020, 72Khanna, DineshLin, Celia J. F.Spotswood, HelenSiegel, JeffreyFurst, DanielDenton, Christopher
- [22] A Randomized, Controlled, Open-label Trial Evaluating the Efficacy and Safety of Chloroquine in the Treatment of Giardiasis in ChildrenWEST INDIAN MEDICAL JOURNAL, 2010, 59 (06): : 607 - 611Canete, R.Rivas, D. E.Escobedo, A. A.Gonzalez, M. E.Almirall, P.Brito, K.
- [23] Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3 noninferiority trialLANCET REGIONAL HEALTH-EUROPE, 2025, 52Paez-Vega, AuroraVaquero-Barrios, Jose M.Ruiz-Arabi, ElisaIturbe-Fernandez, DavidAlonso, RodrigoUssetti-Gil, PiedadMonforte, VictorPastor, AmparoFernandez-Moreno, RaquelMora, Victor M.Erro-Iribarren, MartaQuezada, Carlos A.Berastegui, CristinaCifrian-Martinez, Jose M.Cano, AngelaCaston, Juan J.Machuca, IsabelLobo-Acosta, Maria A.Gutierrez-Gutierrez, BelenCantisan, SaraTorre-Cisneros, Julian
- [24] Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open-label, multicentre, phase IIIb studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (08) : 1007 - 1013Papp, K.Ho, V.Teixeira, H. D.Guerette, B.Chen, K.Lynde, C.
- [25] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIALANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 390 - 390Khanna, D.Lin, C. J. F.Spotswood, H.Siegel, J.Furst, D.Denton, C.
- [26] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical TrialPANCREAS, 2018, 47 (03) : 350 - 350Pavel, MarianneBenavent, MartaPerros, PetrosSrirajaskanthan, RajWarner, Richard R. P.Kulke, Matthew H.Anthony, Lowell B.Kunz, Pamela L.Hoersch, DieterLapuerta, PabloFleming, RosannaGross, David J.
- [27] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical TrialNEUROENDOCRINOLOGY, 2017, 105 : 205 - 205Pavel, M.Benavent, M.Perros, P.Srirajaskanthan, R.Warner, R. R. P.Kulke, M. H.Anthony, L. B.Kunz, P.Hoersch, D.Lapuerta, P.Fleming, R.Gross, D.
- [28] Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3trialLANCET HAEMATOLOGY, 2024, 11 (10): : e729 - e740Harrison, Claire N.Mesa, RubenTalpaz, MosheAl-Ali, Haifa KathrinXicoy, BlancaPassamonti, FrancescoPalandri, FrancescaBenevolo, GiuliaVannucchi, Alessandro MariaMediavilla, ClemenceIurlo, AlessandraKim, InhoRose, ShelonitdaBrown, PatrickHernandez, ChristopherWang, JiaKiladjian, Jean-Jacques
- [29] Efficacy and Safety of Open-Label Setmelanotide in Bardet-Biedl Syndrome: a Phase 3 TrialOBESITY, 2021, 29 : 12 - 12Haws, RobertClement, KarineDollfus, HeleneHaqq, AndreaMartos-Moreno, GabrielChung, WendyMittleman, RobertStewart, MurrayWebster, MattYuan, GuojunArgente, Jesus
- [30] The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trialJOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (11) : 886 - 893Miyazaki, TaigaNakamura, ShigekiHashiguchi, KohjiKobayashi, TsutomuFukushima, KiyoyasuFukuda, YuichiKondo, AkiraInoue, YuichiKoga, HironobuSasaki, EisukeNagayoshi, YosukeHigashiyama, YasuhitoYoshida, MasatakaTakazono, TakahiroSaijo, TomomiMorinaga, YoshitomoYamamoto, KazukoImamura, YoshifumiMikushi, ShinyaIzumikawa, KoichiYanagihara, KatsunoriKohno, ShigeruMukae, Hiroshi